Stéphane Roland Etroy
Corporate Officer/Principal bij ARES MANAGEMENT CORPORATION
Profiel
Stéphane Roland Etroy is currently a Partner at European Capital Asset Management Ltd., Ares Management Corp., and Ares Private Equity Group(UK).
Previously, he held positions as Vice Chairman at Elior Participations SCA, Director at Delachaux Group SA and DalCor Pharmaceuticals Canada, Inc., and Investment Manager at Charterhouse Capital Partners LLP.
From 2015 to 2019, he served as Executive Vice-President at CDP Capital Private Equity (United States).
Etroy is a graduate of École des Hautes Études Commerciales de Paris.
Actieve functies van Stéphane Roland Etroy
Bedrijven | Functie | Begin |
---|---|---|
ARES MANAGEMENT CORPORATION | Corporate Officer/Principal | 06-02-2020 |
European Capital Asset Management Ltd.
European Capital Asset Management Ltd. Investment ManagersFinance European Capital Asset Management Ltd is a private equity firm and it is a subsidiary of European Capital Financial Services Ltd, ultimate parent is Ares Management Corp. The firm was established in 2005 and it’s headquarter is London, UK. | Private Equity Investor | 05-02-2020 |
Ares Private Equity Group(UK) | Private Equity Investor | 01-01-2020 |
Eerdere bekende functies van Stéphane Roland Etroy
Bedrijven | Functie | Einde |
---|---|---|
CDP Capital Private Equity (United States)
CDP Capital Private Equity (United States) Investment ManagersFinance Founded in 1995, CDP Capital Private Equity is a private equity firm located in New York City. The firm is a subsidiary of Caisse de dépôt et placement du Québec. | Private Equity Investor | 18-11-2019 |
DELACHAUX GROUP | Directeur/Bestuurslid | - |
Elior Participations SCA
Elior Participations SCA RestaurantsConsumer Services Elior Participations SCA engages in the provision of contract and concession catering services. The company was founded by Francis Markus and Robert Zolade in 1991 and is headquartered in Nanterre, France. | Directeur/Bestuurslid | - |
DalCor Pharmaceuticals Canada, Inc.
DalCor Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology DalCor Pharmaceuticals Canada, Inc. develops precision treatments for cardiovascular diseases. It offers dalcetrapib, a cholesterol ester transfer protein (CETP) inhibitor, as a potential targeted treatment to address the residual cardiovascular risk in patients carrying a specific ADCY9 genetic profile. The company was founded by Andr? Roger Desmarais and is headquartered in Montreal, Canada. | Directeur/Bestuurslid | - |
Charterhouse Capital Partners LLP
Charterhouse Capital Partners LLP Investment ManagersFinance Charterhouse Capital Partners LLP (Charterhouse Cap Partners) is a private equity subsidiary of Charterhouse Development Capital Ltd /Bonnyman/ founded in 1934 by Stuart Douglas Simpson. The firm is headquartered in London, United Kingdom. | Private Equity Investor | - |
Opleiding van Stéphane Roland Etroy
École des Hautes Études Commerciales de Paris | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ARES MANAGEMENT CORPORATION | Finance |
Bedrijven in privébezit | 7 |
---|---|
Charterhouse Capital Partners LLP
Charterhouse Capital Partners LLP Investment ManagersFinance Charterhouse Capital Partners LLP (Charterhouse Cap Partners) is a private equity subsidiary of Charterhouse Development Capital Ltd /Bonnyman/ founded in 1934 by Stuart Douglas Simpson. The firm is headquartered in London, United Kingdom. | Finance |
Elior Participations SCA
Elior Participations SCA RestaurantsConsumer Services Elior Participations SCA engages in the provision of contract and concession catering services. The company was founded by Francis Markus and Robert Zolade in 1991 and is headquartered in Nanterre, France. | Consumer Services |
DalCor Pharmaceuticals Canada, Inc.
DalCor Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology DalCor Pharmaceuticals Canada, Inc. develops precision treatments for cardiovascular diseases. It offers dalcetrapib, a cholesterol ester transfer protein (CETP) inhibitor, as a potential targeted treatment to address the residual cardiovascular risk in patients carrying a specific ADCY9 genetic profile. The company was founded by Andr? Roger Desmarais and is headquartered in Montreal, Canada. | Health Technology |
Delachaux Group SA
Delachaux Group SA Trucks/Construction/Farm MachineryProducer Manufacturing Delachaux Group SA provides engineering solutions in technology-intensive markets. It mainly serves the rail infrastructure, port, aeronautics, logistics and mining sectors. The company was founded in 1902 and is headquartered in Colombes, France. | Producer Manufacturing |
CDP Capital Private Equity (United States)
CDP Capital Private Equity (United States) Investment ManagersFinance Founded in 1995, CDP Capital Private Equity is a private equity firm located in New York City. The firm is a subsidiary of Caisse de dépôt et placement du Québec. | Finance |
European Capital Asset Management Ltd.
European Capital Asset Management Ltd. Investment ManagersFinance European Capital Asset Management Ltd is a private equity firm and it is a subsidiary of European Capital Financial Services Ltd, ultimate parent is Ares Management Corp. The firm was established in 2005 and it’s headquarter is London, UK. | Finance |
Ares Private Equity Group(UK) | Finance |